Does Finasteride Work for Hair Loss?
This is a research-based fact check, not medical advice. The findings summarized here come from peer-reviewed studies and are presented without added opinions. Consult a certified healthcare practitioner before making any treatment decision.
Verdict
Yes. Finasteride 1mg is FDA-approved for male pattern hair loss and is clinically proven to work. A meta-analysis found finasteride increased total hair count by 12.4 hairs per square centimetre at 24 weeks and 16.4 hairs per square centimetre at 48 weeks vs placebo. Hair weight improved by 25.6% at 48 weeks and 35.8% at 96 weeks. Clinical improvement is seen as early as 3 months. Finasteride is not approved for women.
Key takeaways
- Finasteride 1mg is FDA-approved for male pattern hair loss (since 1997) and clinically proven to work.
- +16.4 hairs/cm2 vs placebo at 48 weeks in meta-analysis (12.4 hairs/cm2 at 24 weeks).
- Hair weight improved 25.6% at 48 weeks and 35.8% at 96 weeks vs placebo.
- Clinical improvement is visible as early as 3 months.
- Finasteride is not approved for women and is contraindicated in women who are pregnant or may become pregnant.
- Sexual side effects occur in approximately 1-2% of men in clinical trials.
Clinical evidence for hair regrowth
Finasteride 1mg (Propecia) has been in clinical use for male pattern hair loss since 1997 and is backed by more than two decades of evidence. It works by inhibiting Type II 5-alpha reductase, which reduces the conversion of testosterone to dihydrotestosterone (DHT), the hormone responsible for follicle miniaturisation in pattern hair loss. An overview of all treatment options is in the hair restoration guide. For the full side effect profile including sexual side effects, see our finasteride side effects guide.
A meta-analysis synthesising the clinical trial data found finasteride 1mg/day significantly increased total hair count compared to placebo: mean difference of 12.4 hairs per square centimetre at 24 weeks (p<0.05) and 16.4 hairs per square centimetre at 48 weeks (p<0.05). Hair weight, which captures both count and thickness, improved by 25.6% at 48 weeks and 35.8% at 96 weeks vs placebo. Clinical improvement was observed as early as 3 months in the FDA pivotal trials.
Efficacy at different timepoints
Short-term (3-12 months)
Clinical improvement is detectable from approximately 3 months. By 12 months, most men who will respond to finasteride will have achieved meaningful hair count and weight improvements. The FDA pivotal trial at 12 months showed net hair count increases and improvements in global photographic assessments rated by investigators and by patients.
Long-term (2-5 years)
The 5-year data from the FDA studies showed that finasteride continued to slow the progression of hair loss observed in the placebo group. Hair weight and count improvements were maintained and in some measures continued to improve at 2 years vs 1 year. Long-term data support continued use as an effective maintenance treatment.
Efficacy across hair loss severity
Finasteride has shown efficacy in the vertex (crown) region in all pivotal trials. Its efficacy in the anterior mid-scalp area has also been demonstrated. Efficacy in bitemporal recession (receding hairline at the temples) has not been established and is not included in the FDA approval.
Comparison with topical minoxidil
Both finasteride and topical minoxidil are established treatments for male pattern hair loss but work through different mechanisms: finasteride reduces DHT to slow miniaturisation; minoxidil extends the growth cycle and improves follicle blood flow. Network meta-analyses suggest finasteride and dutasteride may produce greater hair regrowth than topical minoxidil alone in men. Many dermatologists prescribe both together. For minoxidil efficacy data, see our minoxidil efficacy guide.
5mg vs 1mg for hair loss
Finasteride 5mg is approved for benign prostatic hyperplasia (BPH), not for hair loss. The 1mg dose (Propecia) is the FDA-approved hair loss dose. The meta-analysis found that the efficacy of 1mg/day, 5mg/day, and topical finasteride 1% solution were not significantly different for hair loss outcomes. There is no clinical benefit to using 5mg for hair loss, but side effects may be more likely at higher doses.
Evidence at a glance
| Study | Patients | Key finding |
|---|---|---|
| Mella 2010: oral finasteride for pattern hair loss systematic review | Multiple RCTs | Finasteride 1mg significantly increases hair count and weight vs placebo. Clinical improvement from 3 months. |
| Chen 2020: finasteride combined with topical minoxidil | RCT | Combination of finasteride plus topical minoxidil produced superior results to either treatment alone. |
What the research cannot tell you
- Whether you personally will respond to finasteride. No predictor of individual response exists.
- How quickly your hair loss returns after stopping finasteride. Hair loss typically progresses within 12 months of stopping.
- The long-term outcome of stopping finasteride after 10+ years of use.
- Whether finasteride efficacy differs by hair loss subtype (vertex vs frontal) in controlled trials.
- How finasteride performs head-to-head against oral minoxidil in a large RCT.